{
    "Trade/Device Name(s)": [
        "Olympus CK-MB Reagent",
        "CK-MB Reagent"
    ],
    "Submitter Information": "Olympus Life and Material Science Europa GmbH",
    "510(k) Number": "K070835",
    "Predicate Device Reference 510(k) Number(s)": [
        "K971817"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHY"
    ],
    "Summary Letter Date": "March 24, 2007",
    "Summary Letter Received Date": "March 27, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatine Kinase-MB isoenzyme"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Olympus AU400",
        "Olympus AU600",
        "Olympus AU640",
        "Olympus AU2700",
        "Olympus AU5400"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric method",
        "Isoenzyme quantitation"
    ],
    "Methodologies": [
        "Colorimetric detection",
        "Isoenzyme analysis"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Olympus CK-MB Reagent, a system reagent for quantitating CK-MB isoenzyme in serum and plasma using Olympus analyzers",
    "Indications for Use Summary": "Quantitative determination of Creatine Kinase-MB isoenzyme in human serum and heparinized plasma on Olympus analyzers for aiding in diagnosis and treatment of myocardial infarction and muscle diseases",
    "fda_folder": "Clinical Chemistry"
}